Literature DB >> 16374881

Scoutless stepping-table peripheral contrast-enhanced MR angiography.

Wei Li1, Anthony T Vu, Sean Tutton, Belinda S Y Li, Roland Bejm, Linda Pierchala, Robert R Edelman.   

Abstract

PURPOSE: To evaluate the feasibility of a scoutless method, termed EZ-STEP, for stepping-table peripheral contrast-enhanced magnetic resonance angiography (CE-MRA).
MATERIALS AND METHODS: This scoutless method involves the use of a stepping-table, fast 3D MRA acquisition that incorporates spatially nonselective radiofrequency (RF) pulses for excitation to reduce the repetition time (TR). The sequence was tested in a phantom. The EZ-STEP protocol was optimized in four healthy volunteers and used in 15 subjects. The image quality was scored in a blinded fashion and compared with conventional MRA in eight patients.
RESULTS: The acquisition speed of the EZ-STEP sequence was approximately 30% faster in the phantom study compared to the conventional MRA sequence. The total examination time for EZ-STEP was 6 minutes, compared to an average of 23 minutes for conventional MRA. The average image quality scores for EZ-STEP and conventional MRA for stations 1-3 were 3.50 vs. 3.06 (P = 0.087), 3.53 vs. 3.00 (P = 0.033), and 2.97 vs. 2.50 (P = 0.090), respectively.
CONCLUSION: EZ-STEP is a more efficient method than the conventional approach for stepping-table peripheral CE-MRA, and provides comparable or better image quality. This method shortens the examination time substantially and eliminates the risk of failing to image a vessel because of improper positioning of the scan volume. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16374881     DOI: 10.1002/jmri.20476

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  1 in total

Review 1.  Perspectives for preventive screening with total body MRI.

Authors:  Susanne C Ladd; Mark E Ladd
Journal:  Eur Radiol       Date:  2007-06-05       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.